| The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia O Levran, C Attwooll, RT Henry, KL Milton, K Neveling, P Rio, SD Batish, ... Nature genetics 37 (9), 931-933, 2005 | 448 | 2005 |
| Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase: identification of the first molecular lesion causing Farber disease J Koch, S Gärtner, CM Li, LE Quintern, K Bernardo, O Levran, D Schnabel, ... Journal of Biological Chemistry 271 (51), 33110-33115, 1996 | 299 | 1996 |
| Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics MJ Kreek, O Levran, B Reed, SD Schlussman, Y Zhou, ER Butelman The Journal of clinical investigation 122 (10), 3387-3393, 2012 | 282 | 2012 |
| Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells JJ Gregory Jr, JE Wagner, PC Verlander, O Levran, SD Batish, CR Eide, ... Proceedings of the National Academy of Sciences 98 (5), 2532-2537, 2001 | 269 | 2001 |
| Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia JE Wagner, J Tolar, O Levran, T Scholl, A Deffenbaugh, J Satagopan, ... Blood 103 (8), 3226-3229, 2004 | 262 | 2004 |
| Genetic susceptibility to heroin addiction: a candidate gene association study O Levran, D Londono, K O’hara, DA Nielsen, E Peles, J Rotrosen, ... Genes, Brain and Behavior 7 (7), 720-729, 2008 | 229 | 2008 |
| Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia K Offit, O Levran, B Mullaney, K Mah, K Nafa, SD Batish, R Diotti, ... Journal of the National Cancer Institute 95 (20), 1548-1551, 2003 | 211 | 2003 |
| Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients DI Kutler, VB Wreesmann, A Goberdhan, L Ben-Porat, J Satagopan, ... Journal of the National Cancer Institute 95 (22), 1718-1721, 2003 | 198 | 2003 |
| Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. LE Quintern, EH Schuchman, O Levran, M Suchi, K Ferlinz, H Reinke, ... The EMBO journal 8 (9), 2469-2473, 1989 | 197 | 1989 |
| ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence O Levran, K O'Hara, E Peles, D Li, S Barral, B Ray, L Borg, J Ott, ... Human molecular genetics 17 (14), 2219-2227, 2008 | 191 | 2008 |
| Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1) EH Schuchman, O Levran, LV Pereira, RJ Desnick Genomics 12 (2), 197-205, 1992 | 179 | 1992 |
| A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome L Pereira, O Levran, F Ramirez, JR Lynch, B Sykes, RE Pyeritz, HC Dietz New England Journal of Medicine 331 (3), 148-153, 1994 | 171 | 1994 |
| Sequence variation in the Fanconi anemia gene FAA O Levran, T Erlich, N Magdalena, JJ Gregory, SD Batish, PC Verlander, ... Proceedings of the National Academy of Sciences 94 (24), 13051-13056, 1997 | 153 | 1997 |
| Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer M Berwick, JM Satagopan, L Ben-Porat, A Carlson, K Mah, R Henry, ... Cancer research 67 (19), 9591-9596, 2007 | 142 | 2007 |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment V Yuferov, O Levran, D Proudnikov, DA Nielsen, MJ Kreek Annals of the New York Academy of Sciences 1187 (1), 184-207, 2010 | 140 | 2010 |
| CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction O Levran, E Peles, S Hamon, M Randesi, M Adelson, MJ Kreek Addiction biology 18 (4), 709-716, 2013 | 127 | 2013 |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of … TH Schwantes-An, J Zhang, LS Chen, SM Hartz, RC Culverhouse, ... Behavior genetics 46, 151-169, 2016 | 125 | 2016 |
| Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. O Levran, RJ Desnick, EH Schuchman Proceedings of the National Academy of Sciences 88 (9), 3748-3752, 1991 | 125 | 1991 |
| Genotype patterns that contribute to increased risk for or protection from developing heroin addiction DA Nielsen, F Ji, V Yuferov, A Ho, A Chen, O Levran, J Ott, MJ Kreek Molecular psychiatry 13 (4), 417-428, 2008 | 121 | 2008 |
| Heroin addiction in African Americans: a hypothesis‐driven association study O Levran, D Londono, K O'Hara, M Randesi, J Rotrosen, P Casadonte, ... Genes, Brain and Behavior 8 (5), 531-540, 2009 | 118 | 2009 |
